COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
Mainz Biomed to present new pooled colorectal cancer screening data at ASCO 2024 Annual Meeting, showcasing significant advancements in early detection and diagnostic performance -
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
Mainz Biomed to present eAArly DETECT study results at Digestive Disease Week 2024 in Washington, D.C. Revealing high sensitivity and specificity in colorectal cancer screening -
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next-Gen CRC Test
Mainz Biomed reports positive topline results from pooled study evaluating novel mRNA biomarkers and proprietary AI algorithm for integration into pivotal FDA PMA clinical trial for next-gen CRC test
